Syneos Health

$64.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.88 (+3.00%) As of 1:11 PM EST today

Why Robinhood?

You can buy or sell Syneos Health and other stocks, options, and ETFs commission-free!

About SYNH

Syneos Health, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded in 1998 and is headquartered in Morrisville, NC. The listed name for SYNH is Syneos Health, Inc. Class A Common Stock.

CEO
Alistair John Macdonald
Employees
24,000
Headquarters
Morrisville, North Carolina
Founded
1998
Market Cap
6.71B
Price-Earnings Ratio
34.32
Dividend Yield
Average Volume
978.23K
High Today
$64.91
Low Today
$62.71
Open Price
$62.92
Volume
418.24K
52 Week High
$74.25
52 Week Low
$30.02

Collections

SYNH Earnings

$0.00
$0.35
$0.69
$1.04
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 18, Pre-Market

You May Also Like